Topics

Glioblastoma | Treatment | Case reports

Home > Publications > Topics > Glioblastoma > Treatment > Case reports

CHEMOTHERAPY

□ LOMUSTINE

DIAGNOSTIC/PROGNOSTIC TOOLS

□ MAGNETIC RESON IMAGING

□ POSITRON EMISS TOMOGR

ELECTRIC AND MAGNETIC FIELDS

□ ELECTRO-HYPERTHERMIA

□ TUMOR TREATING FIELDS

GENE THERAPY

□ CYTOKINE

MIMICKING CASES

IMMUNOTHERAPY

□ NEOADJUVANT

NUCLEAR MEDICINE

□ THERANOSTICS

OVERALL MANAGEMENT

□ LONG-TERM SURVIVAL

PHARMACOTHERAPY

□ ANTIEPILEPTIC DRUGS

□ ANTIHYPERTENSIVE DRUGS

□ ANTI-ISCHEMIC DRUGS

□ GLUCOCORTICOIDS

PROGRESSION FROM LGG

□ CHOLESTEROL ESTERIFICATION

RADIOTHERAPY

□ BRACHYTHERAPY

□ RADIATION-INDUCED TUMOR

□ RADIONUCLIDE THER

SPECIAL CASES

□ CEREBRAL MALFORMATIONS

□ WITH NEURONAL COMPONENTS

SPECIAL LOCATIONS

□ CEREBELLAR GLIOBLASTOMA

□ EXTRANEURAL METASTASES

□ INTRAVENTRICULAR

□ LEPTOMENINGEAL DISEASE

□ NEURAL METASTASES

□ OPTIC NERVE TUMORS

□ PRIMARY EXTRANEURAL

□ SPINAL CORD GLIOBLASTOMA

SPECIAL PRESENTATIONS

□ ASYNCHRONOUS TUMORS

□ MULTIFOCAL/MULTICENTRIC

□ NEUROFIBROMATOSIS TYPE 1

□ PARKINSONISM

□ POST-TRAUMATIC TUMOR

□ SECOND PRIMARY

□ SYNCHRONOUS TUMORS

SPECIAL THERAPIES

□ HYPERBARIC OXYGEN THER

□ MICROBIOTA

SPECIAL TUMOR TYPES

□ GIANT CELL GLIOBLASTOMA

TARGETED THERAPY

□ BEVACIZUMAB

□ BRAF-MEK-INHIBITORS

□ DABRAFENIB

□ ERDAFITINIB

□ LAROTRECTINIB

□ NIVOLUMAB

□ PEMBROLIZUMAB

□ SOTORASIB

□ TRAMETINIB

□ VABAMETKIB

□ VEBRELTINIB

□ VEMURAFENIB